Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide with Melphalan and Prednisone in Newly Diagnosed Multiple Myeloma
NCT00405756Phase 3Completed
- Sponsor
- Celgene Corporation
- Start
- Jan 2007
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 22
01
Overview
A Phase 3 trial of lenalidomide in multiple myeloma (MM), sponsored by Celgene Corporation. Started Jan 2007; status: completed.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00405756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00405756.